Alpine Immune Sciences (ALPN) Misses Q3 EPS by 33c

Alpine Immune Sciences (NASDAQ: ALPN) reported Q3 EPS of ($0.42), $0.33 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $8.37 million versus the consensus estimate of $18.69 million.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance